Evidence mapPaperPMID 37722939Full record

ArticleSurgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery2024

Reduced risk of de novo Barrett esophagus after bariatric surgery: a national database study.

Alexander Hurtado, Apoorva K Chandar, Jaime Abraham Perez, Regina Casselberry, Scott A Martin, Kayla DeLano, Mujjahid Abbas, Amitabh Chak

Open access · greenAbstract read
In one paragraph

Article in Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alexander HurtadoCase Western Reserve University School of Medicine, Cleveland, Ohio. Electronic address: amh312@case.edu.
Apoorva K ChandarCase Western Reserve University School of Medicine, Cleveland, Ohio; University Hospitals Cleveland Medical Center, Cleveland, Ohio.
Jaime Abraham PerezUniversity Hospitals Cleveland Medical Center, Cleveland, Ohio.
Regina CasselberryUniversity Hospitals Cleveland Medical Center, Cleveland, Ohio.
Scott A MartinUniversity Hospitals Cleveland Medical Center, Cleveland, Ohio.
Kayla DeLanoTriNetX, LLC, Cambridge, Massachusetts.
Mujjahid AbbasUniversity Hospitals Cleveland Medical Center, Cleveland, Ohio.
Amitabh ChakCase Western Reserve University School of Medicine, Cleveland, Ohio; University Hospitals Cleveland Medical Center, Cleveland, Ohio.
University Hospitals of Cleveland · USTriNetX (United States) · USUniversity School · US

Funding

The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · 2023 to 2025
$3.6M
NCATS NIH HHS UL1 TR000439NCI NIH HHS P50 CA150964NCI NIH HHS U54 CA163060NIDDK NIH HHS P30 DK097948
6 · The paper itself

Abstract

backgroundBariatric surgery is an effective treatment for obesity and may decrease the morbidity and mortality of obesity-associated cancers.

objectiveWe investigated the risk of a new diagnosis of Barrett esophagus (BE) following bariatric surgery compared to screening colonoscopy controls.

settingLarge national database including patients who received care in inpatient, outpatient, and specialty care services.

methodsA national healthcare database (TriNetX, LLC) was used for this analysis. Cases included adults (aged ≥18 yr) who had undergone either sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB). Controls included adults undergoing screening colonoscopy and an esophagoduodenoscopy on the same day and had never undergone bariatric surgery. Cases and controls were propensity-matched for confounders. The risk of de novo diagnosis of BE at least 1 year after bariatric surgery was compared between cases and controls. Secondary analyses examined the effect of bariatric surgery on metabolic outcomes such as weight loss and body mass index (BMI). The risk of de novo diagnosis of BE in SG was compared with RYGB. Odds ratios (OR) and 95% CI were used to report on these associations.

resultsIn the propensity-matched analysis, patients who had undergone a bariatric surgical procedure showed a significantly reduced risk of de novo BE when compared with screening colonoscopy controls (.67 [.48, .94]). There was substantial reduction in weight and BMI in the bariatric surgery group when compared with baseline. There was no significant difference in de novo BE diagnosis between the propensity-matched SG and RYGB groups (.77 [.5, 1.2]).

conclusionPatients who underwent bariatric surgery (RYGB or SG) had a lower risk of being diagnosed with BE compared with screening colonoscopy controls who did not receive bariatric surgery. This effect appears to be largely mediated by reduction in weight and BMI.

Indexed as

Bariatric SurgeryBarrett EsophagusGastric BypassObesity, MorbidAdultGastrectomyHumansObesityRetrospective StudiesTreatment OutcomeBariatric surgeryBarrett’s esophagusRoux-en-Y gastric bypassSleeve gastrectomy

Identifiers

PMID37722939
PMCPMC10843733
OpenAlexW4385989123

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.